// Script to change toggle default state //G Smith second script to show/hide Leadership sections

In The News

NeOnc Technologies Holdings is committed to providing the latest information on its patented and novel drug-delivery technology platform. The following offers media releases related to the company and its progress.

USC-licensed Startup NeOnc Technologies Celebrates NASDAQ Listing

March 25, 2025

NASDAQ’s opening bell will ring for USC research startup

March 25, 2025

Pioneering a New Era in BRAIN CANCER TREATMENT with NASDAQ Listing

March 19, 2025

Building biotech excellence: the growth strategy behind NeOnc Technologies’ vision

March 13, 2025

Expanding horizons: NeOnc Technologies’ bold vision

Feb 19, 2025

Healthcare Entrepreneurs Express Hope, Concern Over RFK Jr. Confirmation

Feb 15, 2025

Revolutionizing The Fight Against Cancer

Feb 5, 2025

A Nose for Attacking Brain Cancer

Feb 4, 2025

Disrupting Biotech: The Business Model Behind NeOnc Technologies

Jan 17, 2025

Revolutionizing Biotech: How NeOnc Technologies Is Striving To Transform Brain Cancer Treatment And Drive Industry Innovation

Jan 13, 2025

Focused on Development of Innovative Drug Delivery Solutions

Jan 5, 2025

Empowering Cancer Patients: NeOnc’s Home-Based Treatment Gives Control Back

Dec 16, 2024

The Man Behind the Mission: Dr. Thomas Chen’s Vision for Brain Cancer Treatment

Dec 2, 2024

Innovative strategy: NeOnc’s bold move in biotech

Nov. 20, 2024

How Professors Can Foster Innovation Amongst The Students They Teach

Nov. 11, 2024

Pharmacy Focus – Oncology Edition: Advancing Brain Cancer Research and Treatment

Sept. 26, 2024

Una empresa de biotecnología que se abre paso a través de la nariz.

Sept.08, 2024

A Biotech Going Through The Nose To Treat The Brian Plots Alternative Path To Public Markets

Sept. 8,2024

NeOnc Wins Drug Delivery Technology of the Year: A New Era in Cancer Treatment

Aug 16,2024

NeOnc Wins Drug Delivery Technology of the Year: A New Era in Cancer Treatment

Aug 16,2024

Q&A: ‘Groundbreaking’ intranasal brain cancer treatment bypasses blood-brain barrier

Aug. 9, 2024

The Man Behind the Mission: Dr. Thomas Chen’s Vision for Brain Cancer Treatment.

Aug 7,2024

Meet the Surgeon Leading a Biotech Revolution: Dr. Thomas Chen’s Fight Against Brain Cancer.

Aug 6, 2024

NeOnc – A New Company and New Approach to Brain Cancer

Aug. 6, 2024

New Approaches and Greater Access to Cancer Care

Aug. 6, 2024

NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

August 2,2024

From Terminal To Thriving: Real Patient Outcomes With NeOnc’s Treatment.

July 29, 2024

NeOnc Noses Into Novel Brain Cancer Treatment.

July 25,2024

Venture Capital Post Discusses NeOnc’s Path To A Direct Public Offering.

July 15, 2024

Healing at Home: How NeOnc’s Innovative Treatment Brings Brain Cancer Care to Patients’ Doorsteps.

July 15, 2024

Revolutionizing Brain Cancer Treatment: NeOnc Introduces First Non-Invasive Intranasal Drug Delivery for Brain Cancer.

July 12, 2024

Pioneering Non-Invasive Treatments: NeOnc’s Breakthrough in Brain Cancer Care.

July 10, 2024